Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-02-21

Clinical Trial Update: Effect of Citalopram on Chest Pain in Patients With Functional Chest Pain [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating citalopram for functional chest pain has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Citalopram (Citalopram hydrobromide)

Snippet

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Conditions: Functional Chest Pain | Phase 4 | Status: TERMINATED